Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIOCRYST PHARMACEUTICALS INCBCRX · Entity 315 | Director | August 31, 2026 | September 02, 2026 |
| PRECIGEN, INC.PGEN · Entity 4356 | Director | March 13, 2026 | March 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIOCRYST PHARMACEUTICALS INC
Report date August 31, 2026 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,747 |
Reported balance
After 2026-08-31 transaction · row 1
1 source rowRow 1 · 2026-08-31 · Grant · Acquired 1,288 · Balance 36,747 F1: Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $12,500. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $12,500.
PRECIGEN, INC.
Report date March 13, 2026 · Filed March 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,226,391 |
Reported balance
After 2026-03-13 transaction · row 1
1 source rowRow 1 · 2026-03-13 · Exercise / conversion · Acquired 71,839 · Balance 1,226,391 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-03-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-03-13 · Exercise / conversion · Disposed 71,839 · Balance 0 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2: The RSUs vested in full on March 13, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
F2: The RSUs vested in full on March 13, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2020 Filed Mar 10, 2020 20:19 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 24,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-20-000539 · edgar.xml · derivative · entry 2 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,703 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F2 · derivative.exercise_date: The restricted stock units vested in full on March 8, 2020. F2 · derivative.expiration_date: The restricted stock units vested in full on March 8, 2020. Read SEC document |
| March 08, 2020 Filed Mar 10, 2020 20:19 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 24,703 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-20-000539 · edgar.xml · nonDerivative · entry 1 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. Read SEC document |
| March 23, 2019 Filed Mar 26, 2019 21:50 UTC | PRECIGEN, INC. XON · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 7,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000574 · edgar.xml · derivative · entry 2 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,911 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F2 · derivative.exercise_date: The restricted stock units vested in full on March 23, 2019. F2 · derivative.expiration_date: The restricted stock units vested in full on March 23, 2019. Read SEC document |
| March 23, 2019 Filed Mar 26, 2019 21:50 UTC | PRECIGEN, INC. XON · Entity 4356 | Exercise / conversionCommon Stock | 7,911 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000574 · edgar.xml · nonDerivative · entry 1 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 23:08 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 42,450 | $0.00 Strike: $5.06 | $0.00 |
DisclosureSEC source: 0001123292-19-000466 · edgar.xml · derivative · entry 3 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,450 Underlying: Common Stock · 42,450 shares Expires 2029-03-08 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 23:08 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantRestricted Stock Units · Derivative | 24,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000466 · edgar.xml · derivative · entry 2 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,614 Underlying: Common Stock · 24,703 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units vest in full one year from the grant date. F3 · derivative.expiration_date: The restricted stock units vest in full one year from the grant date. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 23:08 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantCommon Stock | 9,881 | $5.06 | $49,997.86 |
DisclosureSEC source: 0001123292-19-000466 · edgar.xml · nonDerivative · entry 1 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,106 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $50,000. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:41 UTC | PRECIGEN, INC. XON · Entity 4356 | Exercise / conversionOption to Purchase Common Stock (Right to Buy) · Derivative | 2,968 | $0.00 Strike: $3.17 | $0.00 |
DisclosureSEC source: 0001123292-19-000260 · edgar.xml · derivative · entry 2 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,968 shares Expires 2019-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option was immediately exercisable. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:41 UTC | PRECIGEN, INC. XON · Entity 4356 | Exercise / conversionCommon Stock | 2,968 | $3.17 | $9,408.56 |
DisclosureSEC source: 0001123292-19-000260 · edgar.xml · nonDerivative · entry 1 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2018 Filed Mar 29, 2018 21:54 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 14,246 | $0.00 Strike: $15.80 | $0.00 |
DisclosureSEC source: 0001123292-18-000595 · edgar.xml · derivative · entry 3 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,246 Underlying: Common Stock · 14,246 shares Expires 2028-03-23 Read SEC document |
| March 23, 2018 Filed Mar 29, 2018 21:54 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantRestricted Stock Units · Derivative | 7,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-18-000595 · edgar.xml · derivative · entry 2 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,911 Underlying: Common Stock · 7,911 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units vest in full one year from the grant date. F3 · derivative.expiration_date: The restricted stock units vest in full one year from the grant date. Read SEC document |
| March 23, 2018 Filed Mar 29, 2018 21:54 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantCommon Stock | 3,164 | $15.80 | $49,991.20 |
DisclosureSEC source: 0001123292-18-000595 · edgar.xml · nonDerivative · entry 1 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,257 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $50,000. Read SEC document |
| February 12, 2018 Filed Feb 15, 2018 01:06 UTC | PRECIGEN, INC. XON · Entity 4356 | Exercise / conversionOption to Purchase Common Stock (Right to Buy) · Derivative | 8,906 | $0.00 Strike: $2.64 | $0.00 |
DisclosureSEC source: 0001123292-18-000353 · edgar.xml · derivative · entry 2 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,906 shares Expires 2018-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2018 Filed Feb 15, 2018 01:06 UTC | PRECIGEN, INC. XON · Entity 4356 | Exercise / conversionCommon Stock | 8,906 | $2.64 | $23,511.84 |
DisclosureSEC source: 0001123292-18-000353 · edgar.xml · nonDerivative · entry 1 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,093 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 21:41 UTC | PRECIGEN, INC. XON · Entity 4356 | OtherCommon Stock | 137,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001225385-17-000089 · edgar.xml · nonDerivative · entry 1 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,187 F1 · kind: New River Management V, LP ("NRM V") made a liquidating distribution of its assets to its partners in connection with the dissolution of the partnership in accordance with the terms of the limited partnership agreement. Mr. Frank was a limited partner in NRM V and acquired beneficial ownership of the common stock to which this Form 4 relates on the date set forth in Column 2 of Table 1. Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 20:21 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $21.38 | $0.00 |
DisclosureSEC source: 0001225385-17-000050 · edgar.xml · derivative · entry 2 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-03-16 Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 20:21 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantCommon Stock | 2,806 | $0.00 | $0.00 |
DisclosureSEC source: 0001225385-17-000050 · edgar.xml · nonDerivative · entry 1 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,041 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.